Meridian Bioscience announces anticipated closing date of pending merger

Meridian Bioscience announced that it has entered into a side letter with the buyer, setting the closing date of Meridian’s pending merger for January 31, 2023. As previously disclosed, on July 7, 2022, Meridian, entered into an Agreement and Plan of Merger with SD Biosensor, Columbus Holding Company, and Madeira Acquisition, a direct wholly owned subsidiary of Parent. On December 9, 2022, Meridian and the Parent Parties, entered into a letter agreement, modifying the Merger Agreement. In the Letter Agreement, Meridian and the Parent Parties agreed that all of the conditions to the Parent Parties’ obligations to complete the Merger set forth in the Merger Agreement are satisfied, provided that the Company is required to comply with certain covenants in the Merger Agreement through the completion of the Merger. Meridian and the Parent Parties also agreed to consummate the Merger on January 31, 2023 and to waive their right to terminate the Merger Agreement if the Merger has not been consummated by 11:59 p.m. Eastern Time on January 6, 2023. In agreeing to consummate the Merger on January 31, 2023, the board of directors of Meridian determined that it is in the best interest of Meridian’s shareholders to provide the Parent Parties additional time to consummate the Merger in order to finalize their financing.